Literature DB >> 20883479

Early oncological outcomes for bladder urothelial carcinoma patients treated with robotic-assisted radical cystectomy.

Eric C Kauffman1, Casey K Ng, Ming Ming Lee, Brandon J Otto, Gerald J Wang, Douglas S Scherr.   

Abstract

OBJECTIVE: • To determine oncological outcomes including early survival rates among unselected bladder urothelial carcinoma (BUC) patients treated with robotic-assisted radical cystectomy (RRC). PATIENTS AND METHODS: • Clinicopathologic and survival data were prospectively gathered for 85 consecutive BUC patients treated with RRC. • The decision to undergo a robotic rather than open approach was made without regard to tumor volume or surgical candidacy. • Kaplan-Meier survival rates were determined and stratified by tumor stage and LN positivity, and multivariate analysis was performed to identify independent predictors of survival.
RESULTS:Patients were relatively old (25% >80 years; median 73.5 years), with frequent comorbidities (46% with ASA class ≥ 3). Of these patients 28% had undergone previous pelvic radiation or pelvic surgery, and 20% had received neoadjuvant chemotherapy. • Extended pelvic lymphadenectomy was performed in 98% of patients, with on average 19.1 LN retrieved. • On final pathology, extravesical disease was common (36.5%). • Positive surgicalmargins were detected in five (6%) patients, all of whom had extravesical tumors with perineural and/or lymphovascular invasion, and most of whom were >80 years old. • At a mean postoperative interval of 18 months, 20 (24%) patients had developed recurrent disease, but only three (4%) patients had recurrence locally. Disease-free, cancer-specific and overall survival rates at 2 years were 74%, 85% and 79%, respectively. Patients with low-stage/LN(-) cancers had significantly better survival than extravesical/LN(-) or any-stage/LN(+) patients, with stage being the most important predictor on multivariate analysis.
CONCLUSION: • RRC can achieve adequately high LN yields with a low positive margin rate among unselected BUC patients. • Early survival outcomes are similar to those reported in contemporary open series, with an encouragingly low incidence of local recurrence, however long-term follow-up and head-to-head comparison with the open approach are still needed.
© 2010 THE AUTHORS. JOURNAL COMPILATION © 2010 BJU INTERNATIONAL.

Entities:  

Mesh:

Year:  2010        PMID: 20883479     DOI: 10.1111/j.1464-410X.2010.09577.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  13 in total

Review 1.  The Role of Robotics in the Invasive Management of Bladder Cancer.

Authors:  Pramit Khetrapal; Wei Shen Tan; Benjamin Lamb; Melanie Tan; Hilary Baker; James Thompson; Ashwin Sridhar; John D Kelly; Tim Briggs
Journal:  Curr Urol Rep       Date:  2017-08       Impact factor: 3.092

Review 2.  [Robot-assisted radical cystectomy: do we actually need a robot?].

Authors:  G Niegisch; P Albers; R Rabenalt
Journal:  Urologe A       Date:  2012-03       Impact factor: 0.639

3.  Status of Robot-Assisted Radical Cystectomy (RARC) in 2012.

Authors:  Amrith R Rao; Andrew P Stegemann; Shabnam Rehman; Michael A Poch; Dawn Green; Khurshid A Guru
Journal:  Indian J Surg Oncol       Date:  2012-02-16

4.  The emergence of surgeon-controlled robotic surgery in urologic oncology.

Authors:  Timil H Patel; Paurush Babbar; Ashok K Hemal
Journal:  Indian J Surg Oncol       Date:  2011-12-07

5.  Robotic Intracorporeal Continent Cutaneous Urinary Diversion: Primary Description.

Authors:  Alvin C Goh; Monty A Aghazadeh; Ross E Krasnow; Alexander W Pastuszak; Julie N Stewart; Brian J Miles
Journal:  J Endourol       Date:  2015-02-05       Impact factor: 2.942

Review 6.  Current Status of Robot-Assisted Radical Cystectomy and Intracorporeal Urinary Diversion.

Authors:  Raj Kurpad; Michael Woods; Raj Pruthi
Journal:  Curr Urol Rep       Date:  2016-06       Impact factor: 3.092

Review 7.  Robotic-assisted laparoscopic radical cystectomy: history, techniques and outcomes.

Authors:  Michael A Liss; A Karim Kader
Journal:  World J Urol       Date:  2013-03-20       Impact factor: 4.226

8.  Efficacy of robot-assisted radical cystectomy (RARC) in advanced bladder cancer: results from the International Radical Cystectomy Consortium (IRCC).

Authors:  Ali Al-Daghmin; Eric C Kauffman; Yi Shi; Ketan Badani; M Derya Balbay; Erdem Canda; Prokar Dasgupta; Reza Ghavamian; Robert Grubb; Ashok Hemal; Jihad Kaouk; Adam S Kibel; Thomas Maatman; Mani Menon; Alex Mottrie; Kenneth Nepple; John G Pattaras; James O Peabody; Vassilis Poulakis; Raj Pruthi; Juan Palou Redorta; Koon-Ho Rha; Lee Richstone; Francis Schanne; Douglas S Scherr; Stefan Siemer; Michael Stöckle; Eric M Wallen; Alon Weizer; Peter Wiklund; Timothy Wilson; Gregory Wilding; Michael Woods; Khurshid A Guru
Journal:  BJU Int       Date:  2014-05-22       Impact factor: 5.588

9.  Impact of surgeon and volume on extended lymphadenectomy at the time of robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium (IRCC).

Authors:  Susan J Marshall; Matthew H Hayn; Andrew P Stegemann; Piyush K Agarwal; Ketan K Badani; M Derya Balbay; Prokar Dasgupta; Ashok K Hemal; Brent K Hollenbeck; Adam S Kibel; Mani Menon; Alex Mottrie; Kenneth Nepple; John G Pattaras; James O Peabody; Vassilis Poulakis; Raj S Pruthi; Joan Palou Redorta; Koon-Ho Rha; Lee Richstone; Francis Schanne; Douglas S Scherr; Stefan Siemer; Michael Stöckle; Eric M Wallen; Alon Z Weizer; Peter Wiklund; Timothy Wilson; Michael Woods; Khurshid A Guru
Journal:  BJU Int       Date:  2013-02-26       Impact factor: 5.588

Review 10.  Recent advances in the diagnosis and treatment of bladder cancer.

Authors:  Grace Cheung; Arun Sahai; Michele Billia; Prokar Dasgupta; Muhammad S Khan
Journal:  BMC Med       Date:  2013-01-17       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.